Piramal Pharma Limited — Updates, 13-04-2026: General Updates
13-04-2026 | 10:23 am
13-04-2026 | 10:23 am
Piramal Pharma successfully closed the US FDA inspection at its Lexington, USA manufacturing facility. The FDA issued an EIR with VAI, indicating a positive outcome. This ensures operational stability for the company.
No comments yet. Be the first to comment!
